Works about THERAPEUTIC use of antimetabolites

Results: 638
    1
    2
    3
    4
    5
    6

    Comparison of the Efficacy and Safety of 3 Months of CAPOX Followed by 3 Months of Capecitabine and 6 Months of CAPOX/FOLFOX in the Adjuvant Treatment of Low-Risk Stage III Colon Cancer Treated Surgically.

    Published in:
    Oncology, 2023, v. 101, n. 11, p. 723, doi. 10.1159/000531722
    By:
    • Bardakci, Murat;
    • Demirtas Esmer, Derya;
    • Hafizoglu, Emre;
    • Yaslikaya, Sendag;
    • Genc, Tugrul Burak;
    • Ozcelik, Melike;
    • Erdat, Efe Cem;
    • Hendem, Engin;
    • Buyukbayram, Mehmet Emin;
    • Alaca Topcu, Zeynep;
    • Kalkan, Ziya;
    • Yildirim, Nilgun;
    • Celebi, Abdussamet;
    • Ergun, Yakup;
    • Paydas, Semra;
    • Tatli, Ali Murat;
    • Karakas, Hilal;
    • Koseci, Tolga;
    • Sendur, Mehmet Ali Nahit
    Publication type:
    Article
    7
    8
    9
    10

    A Phase II Study of Cisplatin Plus Gemcitabine followed by Maintenance Gemcitabine for Advanced Squamous Non-Small-Cell Lung Cancer: Kyoto Thoracic Oncology Research Group 1302.

    Published in:
    Oncology, 2019, v. 97, n. 6, p. 327, doi. 10.1159/000501967
    By:
    • Ikeda, Satoshi;
    • Yoshioka, Hiroshige;
    • Kaneda, Toshihiko;
    • Yokoyama, Toshihide;
    • Niwa, Takashi;
    • Sone, Naoyuki;
    • Ishida, Tadashi;
    • Morita, Mitsunori;
    • Tomioka, Hiromi;
    • Komaki, Chihito;
    • Hirabayashi, Masataka;
    • Hasegawa, Yoshinori;
    • Noguchi, Tetsuo;
    • Nakano, Yasutaka;
    • Sakaguchi, Chikara;
    • Yoshimura, Kenichi;
    • Hirai, Toyohiro
    Publication type:
    Article
    11
    12
    13
    14

    Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma.

    Published in:
    Oncology, 2019, v. 96, n. 2, p. 59, doi. 10.1159/000492597
    By:
    • Kim, Jee Hung;
    • Park, Hyung Soon;
    • Heo, Su Jin;
    • Kim, Sang Kyum;
    • Han, Jung Woo;
    • Shin, Kyoo-Ho;
    • Kim, Seung Hyun;
    • Hur, Hyuk;
    • Kim, Kyung Sik;
    • Choi, Young Deuk;
    • Kim, Sunghoon;
    • Lee, Young Han;
    • Suh, Jin-Suck;
    • Ahn, Joong-Bae;
    • Chung, Hyun Cheol;
    • Noh, Sung Hoon;
    • Rha, Sun Young;
    • Kim, Hyo Song
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21

    Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9).

    Published in:
    Oncology, 2014, v. 86, n. 5/6, p. 351, doi. 10.1159/000358730
    By:
    • Esposito, Francesca;
    • Cecere, Sabrina Chiara;
    • Magazzino, Francescapaola;
    • Katsaros, Dionyssios;
    • Ottaiano, Alessandro;
    • Gadducci, Angiolo;
    • Pisano, Carmela;
    • Scalone, Simona;
    • Rabaiotti, Emanuela;
    • Salutari, Vanda;
    • Cormio, Gennaro;
    • Canuto, Emilie Marion;
    • Greggi, Stefano;
    • Savarese, Antonella;
    • Marinaccio, Marco;
    • Scollo, Paolo;
    • Santeufemia, Davide Adriano;
    • Sacco, Cosimo;
    • Facchini, Gaetano;
    • Pignata, Sandro
    Publication type:
    Article
    22

    Bevacizumab + Capecitabine as Maintenance Therapy after Initial Bevacizumab + XELOX Treatment in Previously Untreated Patients with Metastatic Colorectal Cancer: Phase III 'Stop and Go' Study Results - A Turkish Oncology Group Trial.

    Published in:
    Oncology, 2013, v. 85, n. 6, p. 328, doi. 10.1159/000355914
    By:
    • Yalcin, Suayib;
    • Uslu, Ruchan;
    • Dane, Faysal;
    • Yilmaz, Ugur;
    • Zengin, Nurullah;
    • Buyukunal, Evin;
    • Buyukberber, Suleyman;
    • Camci, Celalettin;
    • Sencan, Orhan;
    • Kilickap, Sadettin;
    • Ozdener, Fatih;
    • Cevik, Duygu
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31

    Efficacy of Capecitabine and Temozolomide Regimen in Neuroendocrine Tumors: Data From the Turkish Oncology Group.

    Published in:
    Oncologist, 2023, v. 28, n. 10, p. 875, doi. 10.1093/oncolo/oyad257
    By:
    • Ünal, Çağlar;
    • Azizy, Abdulmunir;
    • Karabulut, Senem;
    • Taştekin, Didem;
    • Akyıldız, Arif;
    • Yaşar, Serkan;
    • Yalçın, Şuayib;
    • Çoban, Eyüp;
    • Evrensel, Türkkan;
    • Kalkan, Ziya;
    • Oruç, Zeynep;
    • Derin, Sümeyra;
    • Turna, Zeynep Hande;
    • Bayram, Doğan;
    • Köş, Fahriye Tuğba;
    • Şendur, Mehmet Ali Nihat;
    • Sever, Nadiye;
    • Ercelep, Özlem;
    • Seyyar, Mustafa;
    • Kefeli, Umut
    Publication type:
    Article
    32
    33

    Three-Year Outcomes of a Phase II Study of Perioperative Capecitabine Plus Oxaliplatin Therapy for Clinical SS/SE N1-3 M0 Gastric Cancer (OGSG 1601).

    Published in:
    Oncologist, 2022, v. 27, n. 4, p. 251, doi. 10.1093/oncolo/oyab061
    By:
    • Matsuyama, Jin;
    • Terazawa, Tetsuji;
    • Goto, Masahiro;
    • Kawabata, Ryohei;
    • Endo, Shunji;
    • Imano, Motohiro;
    • Fujita, Shoichiro;
    • Akamaru, Yusuke;
    • Taniguchi, Hirokazu;
    • Tatsumi, Mitsutoshi;
    • Lee, Sang-Woong;
    • Kawakami, Hisato;
    • Kurokawa, Yukinori;
    • Shimokawa, Toshio;
    • Sakai, Daisuke;
    • Kato, Takeshi;
    • Fujitani, Kazumasa;
    • Satoh, Taroh
    Publication type:
    Article
    34

    Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma.

    Published in:
    Oncologist, 2022, v. 27, n. 3, p. e273, doi. 10.1093/oncolo/oyab073
    By:
    • Monge, Cecilia;
    • Pehrsson, Erica C;
    • Xie, Changqing;
    • Duffy, Austin G;
    • Mabry, Donna;
    • Wood, Bradford J;
    • Kleiner, David E;
    • Steinberg, Seth M;
    • Figg, William D;
    • Redd, Bernadette;
    • Budhu, Anuradha;
    • Wang, Sophie;
    • Tandon, Mayank;
    • Ma, Lichun;
    • Wang, Xin Wei;
    • Greten, Tim F
    Publication type:
    Article
    35

    In Reply.

    Published in:
    2021
    By:
    • CORTY, ROBERT W.
    Publication type:
    Letter to the Editor
    36
    37

    Efficacy of Neratinib Plus Capecitabine in the Subgroup of Patients with Central Nervous System Involvement from the NALA Trial.

    Published in:
    Oncologist, 2021, v. 26, n. 8, p. e1327, doi. 10.1002/onco.13830
    By:
    • Hurvitz, Sara A.;
    • Saura, Cristina;
    • Oliveira, Mafalda;
    • Trudeau, Maureen E.;
    • Moy, Beverly;
    • Delaloge, Suzette;
    • Gradishar, William;
    • Kim, Sung‐Bae;
    • Haley, Barbara;
    • Ryvo, Larisa;
    • Dai, Ming‐Shen;
    • Milovanov, Vladimir;
    • Alarcón, Jesús;
    • Kalmadi, Sujith;
    • Cronemberger, Eduardo;
    • Souza, Cristiano;
    • Landeiro, Luciana;
    • Bose, Ron;
    • Bebchuk, Judith;
    • Kabbinavar, Fairooz
    Publication type:
    Article
    38
    39
    40
    41
    42
    43
    44

    Multicenter Phase II Trial of Axitinib Monotherapy for Gemcitabine‐Based Chemotherapy Refractory Advanced Biliary Tract Cancer (AX‐BC Study).

    Published in:
    Oncologist, 2021, v. 26, n. 2, p. 97, doi. 10.1002/onco.13547
    By:
    • Okano, Naohiro;
    • Furuse, Junji;
    • Ueno, Makoto;
    • Morizane, Chigusa;
    • Yamanaka, Takeharu;
    • Ojima, Hidenori;
    • Ozaka, Masato;
    • Sasaki, Mitsuhito;
    • Takahara, Naminatsu;
    • Nakai, Yousuke;
    • Kobayashi, Satoshi;
    • Morimoto, Manabu;
    • Hosoi, Hiroko;
    • Maeno, Satoko;
    • Nagashima, Fumio;
    • Ikeda, Masafumi;
    • Okusaka, Takuji
    Publication type:
    Article
    45
    46

    In Reply.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1819, doi. 10.1002/onco.13538
    By:
    • Vivaldi, Caterina;
    • Fornaro, Lorenzo;
    • Ugolini, Clara;
    • Vasile, Enrico
    Publication type:
    Article
    47

    Safety and Efficacy of Andecaliximab (GS‐5745) Plus Gemcitabine and Nab‐Paclitaxel in Patients with Advanced Pancreatic Adenocarcinoma: Results from a Phase I Study.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. 954, doi. 10.1634/theoncologist.2020-0474
    By:
    • Bendell, Johanna;
    • Sharma, Sunil;
    • Patel, Manish R.;
    • Windsor, Kevin S.;
    • Wainberg, Zev A.;
    • Gordon, Michael;
    • Chaves, Jorge;
    • Berlin, Jordan;
    • Brachmann, Carrie Baker;
    • Zavodovskaya, Marianna;
    • Liu, JieJane;
    • Thai, Dung;
    • Bhargava, Pankaj;
    • Shah, Manish A.;
    • Khan, Saad A.;
    • Starodub, Alexander
    Publication type:
    Article
    48

    The Activity of Chemotherapy in Inflammatory Myofibroblastic Tumors: A Multicenter, European Retrospective Case Series Analysis.

    Published in:
    Oncologist, 2020, v. 25, n. 11, p. e1777, doi. 10.1634/theoncologist.2020-0352
    By:
    • Baldi, Giacomo Giulio;
    • Brahmi, Mehdi;
    • Lo Vullo, Salvatore;
    • Cojocaru, Elena;
    • Mir, Olivier;
    • Casanova, Michela;
    • Vincenzi, Bruno;
    • De Pas, Tommaso Martino;
    • Grignani, Giovanni;
    • Pantaleo, Maria Abbondanza;
    • Blay, Jean Yves;
    • Jones, Robin Lewis;
    • Le Cesne, Axel;
    • Frezza, Anna Maria;
    • Gronchi, Alessandro;
    • Collini, Paola;
    • Dei Tos, Angelo Paolo;
    • Morosi, Carlo;
    • Mariani, Luigi;
    • Casali, Paolo Giovanni
    Publication type:
    Article
    49
    50